Back to MORGAN STANLEY MORGAN STANLEY

FDMTFDMT
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in 4D MOLECULAR THERAPEUTICS IN

MORGAN STANLEY holds 503,020 shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $6.7M as of 2026-Q2. The position was increased (+45.6% shares). FDMT represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$6.7M

Current Shares

503,020

Total Value Change

-$11.7M

Total Shares Change

-1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
503,020
+45.6%
$6.7M0.0%$13.30
37
2026-Q1
Decreased
345,410
-48.6%
$3.2M0.0%$8.46
0
2025-Q4
Decreased
672,695
-19.5%
$5M0.0%$7.58
0
2025-Q3
Decreased
835,911
-9.6%
$7.3M0.0%$8.35
0
2025-Q2
Decreased
924,676
-48.0%
$3.4M0.0%$3.84
0
2025-Q1
Decreased
1.8M
-4.6%
$5.7M0.0%$3.63
0
2024-Q4
Increased
1.9M
+9.4%
$10.4M0.0%$5.30
30
2024-Q3
Increased
1.7M
+16.6%
$18.4M0.0%$10.83
33

Other major holders of FDMT: VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used